Claudia Andreetta

1.7k total citations
41 papers, 831 citations indexed

About

Claudia Andreetta is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Claudia Andreetta has authored 41 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 14 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Claudia Andreetta's work include HER2/EGFR in Cancer Research (10 papers), Breast Cancer Treatment Studies (10 papers) and Cancer Treatment and Pharmacology (9 papers). Claudia Andreetta is often cited by papers focused on HER2/EGFR in Cancer Research (10 papers), Breast Cancer Treatment Studies (10 papers) and Cancer Treatment and Pharmacology (9 papers). Claudia Andreetta collaborates with scholars based in Italy, United States and Switzerland. Claudia Andreetta's co-authors include Fabio Puglisi, Alessandro Marco Minisini, Gianpiero Fasola, Stefania Russo, Mauro Mansutti, A. Piga, Elena Poletto, Marta Bonotto, Lorenzo Gerratana and Giovanni Gerardo Cardellino and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and International Journal of Environmental Research and Public Health.

In The Last Decade

Claudia Andreetta

39 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Andreetta Italy 16 517 296 205 162 81 41 831
Eleni Timotheadou Greece 17 616 1.2× 201 0.7× 222 1.1× 303 1.9× 76 0.9× 76 1.0k
Virpi Rantanen Finland 14 411 0.8× 149 0.5× 118 0.6× 283 1.7× 109 1.3× 33 736
Corrine Zarwan United States 13 691 1.3× 214 0.7× 200 1.0× 321 2.0× 47 0.6× 27 1.1k
Gregory Friberg United States 18 722 1.4× 269 0.9× 318 1.6× 504 3.1× 52 0.6× 35 1.2k
Tatsunori Shimoi Japan 16 775 1.5× 176 0.6× 422 2.1× 229 1.4× 243 3.0× 105 1.2k
Antonio Febbraro Italy 18 649 1.3× 241 0.8× 314 1.5× 249 1.5× 78 1.0× 56 1.2k
Encarna Adrover Spain 14 864 1.7× 366 1.2× 177 0.9× 297 1.8× 101 1.2× 40 1.1k
Jana Barinoff Germany 18 593 1.1× 333 1.1× 269 1.3× 159 1.0× 164 2.0× 49 976
Hamdy A. Azim Egypt 19 766 1.5× 252 0.9× 352 1.7× 230 1.4× 141 1.7× 66 1.1k
Hubert Orfeuvre France 15 806 1.6× 281 0.9× 173 0.8× 99 0.6× 151 1.9× 37 1.1k

Countries citing papers authored by Claudia Andreetta

Since Specialization
Citations

This map shows the geographic impact of Claudia Andreetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Andreetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Andreetta more than expected).

Fields of papers citing papers by Claudia Andreetta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Andreetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Andreetta. The network helps show where Claudia Andreetta may publish in the future.

Co-authorship network of co-authors of Claudia Andreetta

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Andreetta. A scholar is included among the top collaborators of Claudia Andreetta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Andreetta. Claudia Andreetta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arcieri, Martina, Claudia Andreetta, Stefano Restaino, et al.. (2024). How BRCA and homologous recombination deficiency change therapeutic strategies in ovarian cancer: a review of literature. Frontiers in Oncology. 14. 1335196–1335196. 15 indexed citations
2.
Macchia, Gabriella, Stefano Restaino, Martina Arcieri, et al.. (2023). Is It Time to Reassess the Role of Radiotherapy Treatment in Ovarian Cancer?. Healthcare. 11(17). 2413–2413. 4 indexed citations
3.
Restaino, Stefano, Martina Arcieri, Anna Biasioli, et al.. (2023). Management of Patients Diagnosed with Endometrial Cancer: Comparison of Guidelines. Cancers. 15(4). 1091–1091. 46 indexed citations
4.
Restaino, Stefano, Laura Mariuzzi, Maria ­Orsaria, et al.. (2022). CUP-syndrome: Inguinal high grade serous ovarian carcinoma lymph node metastases with unknown primary origin – a case report and literature review. Frontiers in Oncology. 12. 3 indexed citations
5.
Scambia, Giovanni, Francesco Raspagliesi, Giorgio Valabrega, et al.. (2022). Randomized phase III trial on trabectedin (ET-743) single agent versus clinician’s choice chemotherapy in recurrent ovarian, primary peritoneal, or fallopian tube cancers of BRCA-mutated or BRCAness phenotype patients (MITO23).. Journal of Clinical Oncology. 40(17_suppl). LBA5504–LBA5504. 4 indexed citations
6.
Londero, Ambrogio P., Maria ­Orsaria, Luigi Viola, et al.. (2022). Survivin, sonic hedgehog, krüppel-like factors, and p53 pathway in serous ovarian cancer: an immunohistochemical study. Human Pathology. 127. 92–101. 4 indexed citations
7.
Basile, Debora, Giada Targato, Marco Alberti, et al.. (2021). 295P Clinical characterization and outcome of a HER2-low metastatic breast cancer (mBC) cohort receiving first-line treatment (1L) with ET +/- CDK 4/6 inhibitor (CDKi). Annals of Oncology. 32. S493–S493. 3 indexed citations
8.
Bartoletti, Michele, Roberta Mazzeo, Maria Grazia Vitale, et al.. (2020). Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva. International Journal of Gynecological Cancer. 30(11). 1672–1677. 18 indexed citations
9.
Bonotto, Marta, Debora Basile, Lorenzo Gerratana, et al.. (2020). Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study. Future Oncology. 16(27). 2059–2073. 2 indexed citations
10.
Targato, Giada, Giacomo Pelizzari, Carla Corvaja, et al.. (2020). 1741P Triage procedures for COVID-19 in an Italian cancer centre. Annals of Oncology. 31. S1018–S1018. 1 indexed citations
11.
Fontanella, Caterina, Amelia Barcellini, Maria Giuseppa Vitale, et al.. (2017). Is chemotherapy worthwhile in patients with high-risk, lymph node negative, FIGO stage 1, endometrial cancer?. Annals of Oncology. 28. vi70–vi70. 1 indexed citations
12.
Bonotto, Marta, Lorenzo Gerratana, Elena Poletto, et al.. (2014). Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario. The Oncologist. 19(6). 608–615. 220 indexed citations
13.
Deroma, Laura, Carla Di Loreto, Alessandro Marco Minisini, et al.. (2011). Exploratory predictive and prognostic factors in advanced breast cancer treated with metronomic chemotherapy. Anti-Cancer Drugs. 23(3). 326–334. 15 indexed citations
14.
Andreetta, Claudia, Cinzia Puppin, Francesca Valent, et al.. (2008). Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer. Annals of Oncology. 20(2). 265–271. 48 indexed citations
15.
Puglisi, Fabio, et al.. (2007). Bone Scan for Baseline Staging in Invasive Breast Cancer at the Time of Primary Presentation. Breast Care. 2(6). 358–364. 5 indexed citations
16.
Puglisi, Fabio, Cinzia Puppin, Enrico Pegolo, et al.. (2007). Expression of periostin in human breast cancer. Journal of Clinical Pathology. 61(4). 494–498. 80 indexed citations
17.
Minisini, Alessandro Marco, Dora Fabbro, Carla Di Loreto, et al.. (2007). Markers of the uPA System and Common Prognostic Factors in Breast Cancer. American Journal of Clinical Pathology. 128(1). 112–117. 17 indexed citations
18.
Guarneri, Valentina, Antonio Frassoldati, Guido Ficarra, et al.. (2007). Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer. Breast Cancer Research and Treatment. 110(1). 127–134. 19 indexed citations
19.
Andreetta, Claudia & Ian Smith. (2006). Adjuvant endocrine therapy for early breast cancer. Cancer Letters. 251(1). 17–27. 9 indexed citations
20.
Puglisi, Fabio, Alessandro Follador, Alessandro Marco Minisini, et al.. (2005). Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications. Annals of Oncology. 16(2). 263–266. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eleni Timotheadou Breakdown of academic impact, for papers by Virpi Rantanen Breakdown of academic impact, for papers by Corrine Zarwan Breakdown of academic impact, for papers by Gregory Friberg Breakdown of academic impact, for papers by Tatsunori Shimoi Breakdown of academic impact, for papers by Antonio Febbraro Breakdown of academic impact, for papers by Encarna Adrover Breakdown of academic impact, for papers by Jana Barinoff Breakdown of academic impact, for papers by Hamdy A. Azim Breakdown of academic impact, for papers by Hubert Orfeuvre
Rankless by CCL
2026